Antonio Facchiano

Dr. Antonio Facchiano

Laboratory of Molecular Oncology, Istituto Dermopatico dell’Immacolata, IDI-IRCCS, Rome, Italy
orcid

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2021 in Autophagy
Verified
Journal Article
Closed access
DKDaniel J. Klionsky
Daniel J. Klionsky
AAAmal Kamal Abdel-Aziz
Amal Kamal Abdel-Aziz
SASara Abdelfatah
Sara Abdelfatah
MAMahmoud Abdellatif
Mahmoud Abdellatif
AAAsghar Abdoli
Asghar Abdoli
CTChun-Kit Tong
Chun-Kit Tong

7 April 2019 in BioMed Research International
Verified
Journal Article
Open access
PDF file
Cinzia ForniCinzia Forni
Cinzia Forni
FFFrancesco Facchiano
Francesco Facchiano
MBManuela Bartoli
Manuela Bartoli
SPStefano Pieretti
Stefano Pieretti
AFAntonio Facchiano
Antonio Facchiano
RJRavirajsinh Jadeja
Ravirajsinh Jadeja
Aging is related to a number of functional and morphological changes leading to progressive decline of the biological functions of an organism. Reactive Oxygen Species (ROS), released by several endogenous and exogenous processes, may cause important oxidative damage to DNA, proteins, and lipids, leading to important cellular dysfunctions. The imbalance between ROS production and antioxidant defenses brings to oxidative stress conditions and, related to accumulation of ROS, aging-associated diseases. The purpose of this review is to provide an overview of the most relevant data reported in literature on the natural compounds, mainly phytochemicals, with antioxidant activity and their potential protective effects on age-related diseases such as metabolic syndrome, diabetes, cardiovascular disease, cancer, neurodegenerative disease, and chronic inflammation, and possibly lower side effects, when compared to other drugs.

1 January 2017 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
RMRomina Mancinelli
Romina Mancinelli
GCGuido Carpino
Guido Carpino
SPSimonetta Petrungaro
Simonetta Petrungaro
CMCaterina Loredana Mammola
Caterina Loredana Mammola
LTLuana Tomaipitinca
Luana Tomaipitinca
Claudia GiampietriClaudia Giampietri
Claudia Giampietri
GSK‐3 is a ubiquitously expressed serine/threonine kinase existing as GSK‐3α and GSK‐3β isoforms, both active under basal conditions and inactivated upon phosphorylation by different upstream kinases. Initially discovered as a regulator of glycogen synthesis, GSK‐3 is also involved in several signaling pathways controlling many different key functions. Here, we discuss recent advances regarding (i) GSK‐3 structure, function, regulation, and involvement in several cancers, including hepatocarcinoma, cholangiocarcinoma, breast cancer, prostate cancer, leukemia, and melanoma (active GSK‐3 has been shown to induce apoptosis in some cases or inhibit apoptosis in other cases and to induce cancer progression or inhibit tumor cell proliferation, suggesting that different GSK‐3 modulators may address different specific targets); (ii) GSK‐3 involvement in autophagy modulation, reviewing signaling pathways involved in neurodegenerative and liver diseases; (iii) GSK‐3 role in oxidative stress and autophagic cell death, focusing on liver injury; (iv) GSK‐3 as a possible therapeutic target of natural substances and synthetic inhibitors in many diseases; and (v) GSK‐3 role as modulator of mammalian aging, related to metabolic alterations characterizing senescent cells and age‐related diseases. Studies summarized here underline the GSK‐3 multifaceted role and indicate such kinase as a molecular target in different pathologies, including diseases associated with autophagy dysregulation.

1 October 1988 in Nature
Verified
Journal Article
Closed access
PDF file
LMLucio Miele
Lucio Miele
ECEleonora Cordella-Miele
Eleonora Cordella-Miele
AFAntonio Facchiano
Antonio Facchiano
AMAnil B. Mukherjee
Anil B. Mukherjee

1 September 2016 in Computerized Medical Imaging and Graphics
Verified
Journal Article
Open access
Andrea PennisiAndrea Pennisi
Andrea Pennisi
Domenico Daniele BloisiDomenico Daniele Bloisi
Domenico Daniele Bloisi
DNDaniele Nardi
Daniele Nardi
AGAnna Rita Giampetruzzi
Anna Rita Giampetruzzi
CMChiara Mondino
Chiara Mondino
AFAntonio Facchiano
Antonio Facchiano
Developing automatic diagnostic tools for the early detection of skin cancer lesions in dermoscopic images can help to reduce melanoma-induced mortality. Image segmentation is a key step in the automated skin lesion diagnosis pipeline. In this paper, a fast and fully-automatic algorithm for skin lesion segmentation in dermoscopic images is presented. Delaunay Triangulation is used to extract a binary mask of the lesion region, without the need of any training stage. A quantitative experimental evaluation has been conducted on a publicly available database, by taking into account six well-known state-of-the-art segmentation methods for comparison. The results of the experimental analysis demonstrate that the proposed approach is highly accurate when dealing with benign lesions, while the segmentation accuracy significantly decreases when melanoma images are processed. This behavior led us to consider geometrical and color features extracted from the binary masks generated by our algorithm for classification, achieving promising results for melanoma detection.

28 April 2011 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
MNMaria Grazia Narducci
Maria Grazia Narducci
DAD Arcelli
D Arcelli
MPM C Picchio
M C Picchio
CLC Lazzeri
C Lazzeri
EPE Pagani
E Pagani
GRGiandomenico Russo
Giandomenico Russo
Sézary syndrome (SS) is an incurable leukemic variant of cutaneous T-cell lymphoma and its pathogenesis is still unknown. Diagnosis/prognosis may strongly ameliorate the management of SS individuals. Here, we profiled the expression of 470 microRNAs (miRNAs) in a cohort of 22 SS patients, and we identified 45 miRNAs differentially expressed between SS and controls. Using predictive analysis, a list of 19 miRNAs, including miR-21, miR-214, miR-486, miR-18a, miR-342, miR-31 and let-7 members were also found. Moreover, we defined a signature of 14 miRNAs including again miR-21, potentially able to discriminate patients with unfavorable and favorable outcome. We validated our data for miR-21, miR-214 and miR-486 by qRT-PCR, including an additional set of array-independent SS cases. In addition, we also provide an in vitro evidence for a contribution of miR-214, miR-486 and miR-21 to apoptotic resistance of CTCL cell line.